Britain's National Health Service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the ...

The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...

The bill would implement a moratorium for a decade. “I am not against vaccination in any way,” the freshman lawmaker said.

The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...

AI could deliver substantially greater efficiencies in cell and gene therapy manufacturing and enable more patients to ...

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program to ...

In two new papers, researchers from The Jackson Laboratory (JAX) report the successful use of two approaches—gene therapy and ...

NHS patients with sickle cell disease will be able to benefit from a groundbreaking gene-editing treatment that offers the prospect of a cure for the condition. The one-off gene therapy, known as ...

CDMO Rentschler Biopharma is signalling its intent to cut down cell and gene therapy operations by shutting down its UK ...

MaxCyte, Inc. (NASDAQ: MXCT), a leading cell-engineering focused company, recently announced the acquisition of SeQure DX Inc., a market leader in on-target and off-target editing assessment services ...

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

BOISE — Sen. Brandon Shippy, R-New Plymouth, is proposing to put a 10-year pause on certain types of vaccines that were used ...